Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (year values)

2019 2020 2021 2022 2023   LTM ?
EV/EBITDA ? -2.00 -11.1 -0.09 0.31 -0.20   -0.03
Changes by years, y/y, % -134% +456% -99% -435% -166%    

Black Diamond Therapeutics. EV/EBITDA

Black Diamond Therapeutics. EV/EBITDA, changes, %

Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (quarter values)

2023Q1 2023Q2 2023Q3 2023Q4 2024Q1   LTM ?
EV/EBITDA ? 0.08 -1.39 -0.31 -0.45 -2.03   -0.03
Changes by years, y/y, % -101% -48% -83% -247% -2 742%    
Changes by quarters, q/q, % -75% -1 910% -78% +45% +348%    

Black Diamond Therapeutics. EV/EBITDA

Black Diamond Therapeutics. EV/EBITDA, changes, y/y, %

Black Diamond Therapeutics. EV/EBITDA, changes, q/q, %